ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Panel Urges New Research Consortium For Stomach, Esophageal Cancers

January 17, 2003

NCCS Networker Volume 5 Issue 1, Winter 1991

January 13, 1991

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979

Enck New ACCC President, King President Elect

March 20, 1987

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999